Kakumanu Vasu Kumar, Arora Vinod, Bansal Arvind K
Department of Pharmaceutical Technology (Formulations), National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, Phase X, SAS Nagar, Punjab 160 062, India.
Int J Pharm. 2006 Jul 24;317(2):155-60. doi: 10.1016/j.ijpharm.2006.03.004. Epub 2006 Mar 12.
Learning about the behavior of a drug in biological environment enables application of better formulation strategies to improve bioavailability of the same. Cefpodoxime proxetil (CP) is a prodrug, which is orally administered cephalosporin with only 50% absolute bioavailability. Despite previous studies, reasons responsible for low bioavailability of CP remain poorly understood. The present study tries to ascertain reasons for the low oral bioavailability of CP. The in vitro, in situ and ex vivo studies showed interesting results, where metabolism of CP into cefpodoxime acid (CA) inside the intestinal epithelial cell and preferential efflux of CA into lumen was identified as primary reason for low oral bioavailability of CP. Presence of specific carriers or transportation mechanism on the apical side membrane of enterocyte, than basal side of the same was observed.
了解药物在生物环境中的行为有助于应用更好的制剂策略来提高其生物利用度。头孢泊肟酯(CP)是一种前药,是口服的头孢菌素,绝对生物利用度仅为50%。尽管有先前的研究,但CP生物利用度低的原因仍知之甚少。本研究试图确定CP口服生物利用度低的原因。体外、原位和离体研究显示了有趣的结果,其中CP在肠上皮细胞内代谢为头孢泊肟酸(CA)以及CA优先向肠腔流出被确定为CP口服生物利用度低的主要原因。观察到肠上皮细胞顶端侧膜上存在特定载体或转运机制,而基底侧则没有。